Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Insurance · CIK 0001095073
$407.56
+3.24% · delayed ~15 min
Last price from Oct 22, 2026
$30.32B market value
From EVEREST GROUP, LTD.'s FY2025 10-K, filed Feb 26, 2026 · read the filing
EVEREST sells insurance. It took in $17.50B last year, which makes it a large company. Of every dollar it sells, about 9 cents is left as profit.
The financial picture is mixed, with profitability, growth and debt needing attention.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From EVEREST GROUP, LTD.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Profit
$1.37B → $1.59B
Earnings per share
$18.48 → $21.38
Profit margin
7.9% → 9.1%
Cash
$1.55B → $1.32B
Measured against FY2024, from the 10-K filed Feb 26, 2026
Improved: +15.9%
$1.37B to $1.59BSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
EG rose 3.24% on the latest quote. The average Financials company tracked here moved +1.08%, and the S&P 500 −1.04%. That is 2.2 points above its sector and 4.3 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 27 analysts covering this company, as of . Their views, not this site's.
Of 27 analysts publishing on this company, 5 say strong buy, 9 say buy and 13 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 9 cents of every dollar of sales as profit, earning $1.59B last year.
Barely. Sales were roughly flat, up 1.2%.
For every $1 it owes, it owns $1.33 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 21 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 11% of the cash its operations generated. It has paid in each of the last 12 years.
GoodFigures from the FY2025 annual filing
Last year it earned $1.59B and generated $3.07B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 26, 2026Filing for FY2025 | FY202410-K · Feb 27, 2025Filing for FY2024 | FY202310-K · Feb 28, 2024Filing for FY2023 | FY202210-K · Feb 28, 2024Filing for FY2022 | FY202110-K · Feb 28, 2024Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $17.50B | $17.28B | $14.59B | $12.06B | $11.87B | +1.2% |
| Income before tax | $1.89B | $1.49B | $2.15B | $588.0M | $1.55B | +26.4% |
| Net income | $1.59B | $1.37B | $2.52B | $597.0M | $1.38B | +15.9% |
| Net marginNet income ÷ revenueWhat is this? | 9.1% | 7.9% | 17.3% | 5.0% | 11.6% | +1.1 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $21.38 | $18.48 | $33.92 | $8.54 | $19.76 | +15.7% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 85 shares at $366.47 ($31.1K)
Holds 12,674 shares after this filing.
Was granted or awarded shares — 85 shares at $366.47 ($31.1K)
Holds 2,428 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingWrite down why you are following EVEREST GROUP, LTD., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
SiriusPoint (SPNT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo ·
Everest Group (EG) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo ·
Xceedance Named a Leader and Star Performer in Everest Group’s Insurance Intermediaries Operations PEAK Matrix® Assessment 2026
Yahoo ·
Genpact Awarded Everest Group's 2026 Elevate Honors for Market-Leading Growth
Yahoo ·
Willis Towers Watson Stock And 2 Insurers For Rising US Political Risk
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from EG's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 26, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 6 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 6.0 | 5/6 | 10-K, filed Feb 26, 2026 |
| FY2024 | 7.3 | 5/6 | 10-K, filed Feb 27, 2025 |
| FY2023 | 8.7 | 4/6 | 10-K, filed Feb 28, 2024 |
| FY2022 | 6.0 | 4/6 | 10-K, filed Feb 24, 2023 |
| FY2021 | 8.7 | 6/6 | 10-K, filed Feb 24, 2023 |
| FY2020 | 7.3 | 4/6 | 10-K, filed Feb 28, 2022 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 6 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 3 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +15.7%
$18.48 to $21.38Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +1.1 pts
7.9% to 9.1%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -14.9%
$1.55B to $1.32BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 3, 2026 — read it.
Deteriorated: -41.3%
$1.90B to $1.12BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: -17.8%
$680.0M to $559.0MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: -17.9%
$9.14 to $7.50Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -11.8%
$4.49B to $3.96BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: −1.0 pts
15.1% to 14.1%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 3, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -21.1%
$1.42B to $1.12BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: -14.4%
$653.0M to $559.0MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −1.9 pts
16.1% to 14.1%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -14.4%
$8.77 to $7.50Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
3 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 2.2% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 14.1x — investors pay $14.1 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
Was granted or awarded shares — 85 shares at $366.47 ($31.1K)
Holds 5,472 shares after this filing.
Was granted or awarded shares — 85 shares at $366.47 ($31.1K)
Holds 2,098 shares after this filing.
Had shares withheld to cover taxes — 496 shares at $366.47 ($181.8K)
Holds 7,817 shares after this filing.
Had shares withheld to cover taxes — 456 shares at $366.47 ($167.1K)
Holds 7,714 shares after this filing.
Was granted or awarded shares — 86 shares at $360.78 ($31.0K)
Holds 2,343 shares after this filing.
Was granted or awarded shares — 86 shares at $360.78 ($31.0K)
Holds 5,387 shares after this filing.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Quarterly report for Q2 FY2026
Revenue -11.8% · Profit margin −1.0 pts · Cash -41.3% — against Q2 FY2025
Published results
Read the filingReported another event
Read the filingHad a director or senior officer leave or join · Held a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Profit margin +11.1 pts · Profit +211.0% · Earnings per share +210.5% — against Q1 FY2025
Read the filingPublished results
Read the filingMade a Regulation FD disclosure
Read the filingProxy statement for a shareholder meeting
Read the filingSigned a material agreement · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingAnnual report for FY2025
Profit margin +1.1 pts · Profit +15.9% · Earnings per share +15.7% — against FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q3 FY2025
Profit margin −6.0 pts · Profit -49.9% · Earnings per share -50.0% — against Q3 FY2024
Read the filingSigned a material agreement
Read the filingSigned a material agreement
Read the filingPublished results
Read the filingYahoo ·
Keefe, Bruyette & Woods Maintains Outperform on Everest Group, Lowers Price Target to $407
Benzinga ·
Primary sources and further research